tuberculosis (TB) testing guidelines T-SPOT.TB doctor

Latest guidelines

Periodically, various institutions issue updated tuberculosis (TB) testing guidelines for different populations. This page is a resource, compiling these TB testing guidelines for your convenience and guidance.

World Health Organization Latent TB Infection: Updated and consolidated guidelines for programmatic management 2018

World Health Organization International Standards for Tuberculosis Care

CDC guidelines on use of IGRAs in Tuberculosis Screening, Testing, and Treatment of U.S. Health Care Personnel

National Institute for Health and Care Excellence (NICE) Guidelines on Tuberculosis NG33

Medicines and Healthcare Products Regulatory Agency (MHRA) Alert – Tumour necrosis factor alpha inhibitors and risk of tuberculosis

British Society of Rheumatology 2018 Guidelines for the prescription and monitoring of non-biologic disease-modifying anti-rheumatic drugs (DMARDs)

European Centre for Disease Prevention and Control (ECDC) European Union standards for tuberculosis care

French Public Health Institution (Haut Conseil de la Santé Publique). Latent Tuberculosis Infection. Detection, support and monitoring

French Health Authority Institution (Haute Autorité de Santé). Interferon-gamma release assays as in vitro screening tests for latent tuberculosis infection

German Central Committee against tuberculosis (Deutsches Zentralkomitee zur Bekämpfung der Tuberkulose)